AMG 157

TSLP inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMG 157, covering 2020-05-06 to 2020-05-06. Get the full timeline:

Most recent: Clinical Trial Update: Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy [Phase 1, Phase 2]

See pricing